G

Genelux Corp
D

GNLX

2.50000
USD
-0.02
(-0.79%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
112,014,528
أصول ذات صلة المقالات
المزيد

العنوان: Genelux Corp

القطاع: Healthcare
الصناعة: Biotechnology
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune responseagainst tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.